Trial intelligence / Profile preview

Oxytocin vs carbetocin circulatory effects at cesarean section

2013-004224-10Phase 4Completed

Sponsor
Region Skåne
Start
Oct 2013
Modality
Peptides
Countries
1
01

Overview

Phase 4, randomised trial of carbetocin in pregnancy and circulatory effects of cesarean section (2 arms), sponsored by Region Skåne. Primary endpoints: Maternal ECG ST index changes, Blood pressure changes and 1 more. Started Oct 2013; status: completed.

02

Drugs

carbetocin
03

Conditions

pregnancycirculatory effects of cesarean section

Beyond the preview

Go deeper on 2013-004224-10.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2013-004224-10.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call